# Novel Brain Stimulation Therapies in Stroke Guided Expressions of Plasticity

> **NCT03020433** · EARLY_PHASE1 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 37 (actual)

## Conditions studied

- Stroke
- Cerebrovascular Disorders
- Nervous System Diseases
- Brain Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Central Nervous System Diseases

## Interventions

- **DEVICE:** rTMS Contralesional M1
- **DEVICE:** rTMS Contralesional PMC
- **DEVICE:** rTMS Ipsilesional PMC
- **DEVICE:** rTMS sham at Ipsilesional M1

## Key facts

- **NCT ID:** NCT03020433
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2020-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03020433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03020433, "Novel Brain Stimulation Therapies in Stroke Guided Expressions of Plasticity". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03020433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
